An exploration of the structure-activity relationships of 4-aminoquinolines: Novel antimalarials with activity in-vivo

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 8, 1996, Pages 841-850

  Ismail, F M D ^a   Dascombe, M J ^b   Carr, P ^a   North, S E ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; DRUG TARGETING; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMODIUM BERGHEI; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029787728     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03985.x     Document Type: Article

References (40)

1. Albert, A. (1966) The Acridines, their Preparation, Properties and Uses, 2nd edn. Edward Arnold, London
2. Barlin, G. B., Jiravinyu, C. (1991) Potential antimalarials XIII. Mono-Mannich bases of 4-[7-chloro)- and 7-trifluoromethyl)quinolin-4-ylamino]- and 4-(7-bromo-1,5-napthyridin-4-ylamino)-3-methyl phenol. Aust. J. Chem. 44: 151-156
3. Basco, L. K., Anderson, S. L., Milhous, W. K., Le Bras, J., Venner-strom, J. L. (1994) In vitro activity of bisquinoline WR268668 against African clones and isolates of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 50: 200-205
4. Benazet, F. (1965) Activate d'un nouvel antimalarique, 16,126 R.P. Sur le paludisme experimental des animaux de laboratoire. Bull. Soc. Pathol. Exot. ses Fil. 60: 221-228
5. Berliner, R. W., Earle, D. P., Taggart, J. V., Zubrod, C. J., Welch, W. J., Conan, N. J., Bauman, E., Scudder, S. T., Shannon, J. A. (1948) Studies on the chemotherapy of human malarials: VI. The physiological disposition, antimalarial activity and toxicity of several derivatives of 4-aminoquinoline. J. Clin. Invest. 27: 98-107
6. Biosym Technologies Inc. (1993) Insight II, Version 2.3.0. San Diego, California 92121-27779, USA
7. Boykin, D. W., Patel, A. R., Lutz, R. E. (1968) Antimalarials IV. A new synthesis of α-(2-pyridyl)- and α-(2-piperidyl)-2-aryl-4-quino-linemethanols. J. Med. Chem. 11: 273-277
8. Cain, B. F., Baguley, B. C., Denny, W. A. (1978) Potential antitumour agents: 28. Deoxyribonucleic acid polyintercalating agents. J. Med. Chem. 21: 658-668
9. Chen, T. K., Fico, R., Canellakis, E. S. (1978) Diacridines, bifunctional intercalators. Chemistry and antitumor activity. J. Med. Chem. 21: 868-874
10. Chou, A. C., Chevli, R., Fitch, C. D. (1980) Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19: 1543-1549
11. Coatney, G. R., Cooper, W. C., Eddy, N. B., Greenberg, J. (1953) Survey of Antimalarial Agents: Chemotherapy of Plasmodium gallinaceum Infections; Toxicity; Correlation of Structure and Action. Public Health Service Monograph No. 9, US Government Printing Office, Washington, DC
12. Cohen, S. N., Yielding, K. L. (1965) Inhibition of DNA and RNA polymerase reactions by chloroquine. Proc. Natl. Acad. Sci. USA 54: 521-527
13. Elslager, E. F., Thompson, P. E. (1964) Repository Antimalarial Drugs. Rep. 9th Med. Chem. Symposium. Am. Chem. Soc. 6a-6z
14. Go, M. L., Koh, H. L., Ngiam, T. L., Phillipson, J. D., Kirby, G. C., O'Neill, M. J., Warhurst, D. C. (1992) Synthesis and in vitro antimalarial activity of some indolo[3,2-c] quinolines. Eur. J. Med. Chem. 27: 391-394
15. Haigh, C. W., Palmer, M. H., Semple, B. (1965) Preparation and nuclear magnetic resonance spectra of some halogenoquinolines. Nearly degenerate ABX spectra. J. Chem. Soc. 6004-6019
16. Hansch, C. (1977) On the predictive value of QSAR. In: Keverling Buisman, J. A. (ed.) Biological Activity and Chemical Structure. Pharmacochemistry Library: 2, Elsevier Scientific, pp 47-61
17. Jacob, R. M., Robert, J. G., Liakhoff, L. (1958) Quinoline derivatives. US Patent 2816893, Chem. Abs. (1958) 2934a; Quinoline derivatives, Br. Patent 726568 (1955) Chem. Abs. 4238b
18. Jacob, R. M., Robert, J. G., Liakhoff, L. (1958) Quinoline derivatives. US Patent 2816893, Chem. Abs. (1958) 2934a; Quinoline derivatives, Br. Patent 726568 (1955) Chem. Abs. 4238b
19. Koh, H. L., Go, M. L., Ngiam, T., Mak, J. W. (1994) Conformational and structural features determining in vitro antimalarial activity in some indolo[3,2-c] quinolines, anilinoquinolines and tetrahydroindolo[3,2-d]benzazepines. Eur. J. Med. Chem. 29: 107-113
20. LeBras, J., Deloron, P., Charmot, G. (1983) Dichloroquinazine (a 4-aminoquinoline) effective in vitro against chloroquine-resistant Plasmodiumfalciparum. Lancet 1: 73-74
21. Marquez, V. E., Cranston, J. W., Ruddon, R. W., Bruckhalter, J. W. (1974) Binding to deoxyribonucleic acid and inhibition of ribonucleic acid polymerase by analogs of chloroquine. J. Med. Chem. 17: 856-862
22. Mauss, H., Meitzsch, F., Winthrop Chemical Company (1937) US Patent 2079023, Chem. Abs. 31: 4456
23. McCarron, M., Carr, P., Ismail, F. M. D. (1994) The molecular modelling of a bisquinoline with potential against chloroquine-resistant malaria and its possible pharmacological mechanism of action by computer, BSc Project, Division of Chemical Sciences, University of Hertfordshire, UK
24. Mohamadi, F., Richards, N. G. J., Guida, W. C., Liskamp, R., Caufield, C., Chang, G., Hendrickson, T., Still, W. C. (1990) MacroModel - an integrated software system for modelling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 11: 440-467
25. O'Brien, R., Olenick, J., Hahan, F. (1966) Reactions of quinine, chloroquine, and quinacrine with DNA and their effects on the DNA and RNA polymerase reactions. Natl. Acad. Sci. USA 55: 1511-1517
26. Oxford Molecular Ltd (1993) Personal Interactive Modelling System (PIMMS) Version 1.42, South Parks Rd, Oxford OX1 3UB, UK
27. Pearson, D. E., Jones, W. H., Cope, A. C. (1946) Synthesis of monoalkyl-substituted diamines and their condensation products with 4,7-dichloroquinoline. J. Am. Chem. Soc. 68: 1225-1229
28. Perrin, D. D., Armarego, W. L. (1988) Purification of Laboratory Chemicals, 3rd edn, Pergamon, Oxford
29. Peters, W. (1970) Chemotherapy and Drug Resistance in Malaria, Academic Press, London
30. Schock, R. U. (1957) The preparation of some N,N'-bis-(4-quinaldyl)-αω-diaminoalkanes as potential trypanocides. J. Am. Chem. Soc. 79: 1672-1675
31. Shriver, D. F., Drezdzon, M. A. (1986) The Manipulation of Air-Sensitive Compounds. J. Wiley & Sons, New York
32. Surrey, A. R., Cutler, R. A. (1951) The role of phenol in the reaction of 4,7-dichloroquinoline with novol diamine. J. Am. Chem. Soc. 73: 2623-2626
33. Topliss, J. G. (1972) Utilization of operational schemes for analog synthesis in drug design. J. Med. Chem. 15: 1006-1011
34. Topliss, J. G. (1977) A manual method for applying the Hansch approach to drug design. J. Med. Chem. 20: 463-469
35. Vennerstrom, J. L., Ellis, W. Y., Ager Jr, A. L., Anderson, S. L., Gerena, L., Milhous, W. K. (1992) Bisquinolines 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. J. Med. Chem. 35: 2129-2134
36. Walls, I. P. (1951) Trypanocides, a review. Chem. Ind. 606-610
37. Warhurst, D. C. (1966) Chloroquine-resistant rodent malaria and the long-acting antimalarial 12,278 R. P. Trans. Roy. Soc. Trop. Med. Hyg. 60: 565-566
38. Waring, M. J. (1979) Mechanism of action of antileukaryotic and antiviral compounds. In: Hahn, F. E (ed.) Antibiotics: 2. Springer, New York, pp 173-194
39. Williams, R. T. (1959) Detoxification Mechanisms. John Wiley and Sons, New York, p. 655
40. Zhang, K., Zhou, J., Wu, Z., Huang, Q. (1987) Susceptibility of Plasmodium falciparum to chloroquine, piperaquine, amodiaquine, mefloquine and quinine with in vitro microtechnique in Hainan Island. Chin. J. Parasitol. Parasit. Dis. 5: 165-169